Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Oct. 5, 2000

Mevinolin derivatives for disorders mediated by LFA-1/ICAM-1 interactions

Oct. 3, 2000

Milestone reached in MorphoSys and GPC Biotech immunology therapeutics program

Sep. 28, 2000

SangStat's Thymoglobulin granted orphan drug designation in U.S.

Sep. 26, 2000

Baxter and Peptide Therapeutics enter collaboration for vaccine development

Sep. 22, 2000

Pseudo-proline-containing ciclosporin derivatives useful as prodrugs

Sep. 19, 2000

HuM291 appears to induce transplant tolerance via apoptosis of activated T-cells

Sep. 14, 2000

DNA vaccine encoding C3d enhances immune response to influenza

Sep. 13, 2000

SDZ-RAD continues to shine as a potential agent for transplantation

Sep. 13, 2000

Immunosuppressive effects of new peptide confirmed; additional hypolipidemic effects seen

Sep. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.